Skip To Main Content
Christophe Glorieux on Muck Rack

Christophe Glorieux

As seen in: Nature, MDPI, Texas Medical Center
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Christophe Glorieux’s profile

Articles by Christophe Glorieux

"Cisplatin and Gemcitabine Exert Opposite Effects on Immunotherapy With" by Christophe Glorieux, Xiaojun Xia et al.

|
By Christophe Glorieux, Xiaojun Xia, Xin You, Zining Wang
| Texas Medical Center
INTRODUCTION: Immunochemotherapy using PD-1/PD-L1 antibodies in combination with chemotherapeutic agents has become a mainstream treatment for cancer patients, but it remains unclear which drug combinations would produce best therapeutic outcome. OBJECTIVES: The purpose of this study was to investigate two common chemotherapeutic drugs, gemcitabine and cisplatin, for their impacts on the therapeutic efficacy of PD-1 antibody in K-ras-driven cancers known to overexpress PD-L1.
Open in Who Shared Issue with article?

Targeting ROS in cancer: rationale and strategies - Nature Reviews Drug Discovery

|
By Christophe Glorieux, Shihua Liu, Dunyaporn Trachootham
| Nature Verified
Abstract Reactive oxygen species (ROS) in biological systems are transient but essential molecules that are generated and eliminated by a complex set of delicately balanced molecular machineries. Disruption of redox homeostasis has been associated with various human diseases, especially cancer, in which increased ROS levels are thought to have a major role in tumour development and progression.
Open in Who Shared Issue with article?

The Multifaceted Roles of NRF2 in Cancer: Friend or Foe?

|
By Cinthya Enríquez, Constanza González, Gabriela V. Aguirre-Martínez, Christophe Glorieux
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared Issue with article?
Show More